One of the most striking claims in the review is that AI-based classification models can meet or exceed the performance of ...

A study presented at ESCMID Global 2025 has demonstrated that an AI-powered lung ultrasound outperforms human experts by 9% ...

Researchers found that use of immunosuppressive medication was a strong protective factor, associated with a 60% reduction in ...

A recent publication by the British Thoracic Society offers the first long-term analysis of the UK Idiopathic Pulmonary ...

A pioneering study presented today at ESCMID Global 2025 has demonstrated that an AI-powered lung ultrasound outperforms human experts by 9% in diagnosing pulmonary tuberculosis (TB).

Findings presented at ESCMID Global 2025 highlight the potential of AI-enhanced ultrasound as a frontline diagnostic tool for tuberculosis.

Eric Cannon, PharmD, FAMCP, discusses how precision medicine advancements and biomarker development can enable targeted ...

A study has shown that an AI-powered lung ultrasound outperforms human experts by 9% in diagnosing pulmonary tuberculosis ...

Background: Pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma is a rare, indolent subtype of non-Hodgkin lymphoma ...

The ULTR-AI suite comprises three deep-learning models: ULTR-AI predicts TB directly from lung ultrasound images; ULTR-AI (signs) detects ultrasound patterns as interpreted by human experts ...

Dr Ahmed Fahim discusses the UK Idiopathic Pulmonary Fibrosis Registry and how its findings enhance understanding and ...